AstraZeneca COVID-19 vaccine inoculations are being put on pause in Denmark, as well as Norway, Iceland, and Luxembourg over adverse effect concerns. Whilst Denmark, Norway, Iceland, and Luxembourg have suspended the inoculations with the AstraZeneca vaccine, Italy and Austria have stopped using a certain batch of the vaccine as a precaution.
According to health authorities in Denmark, a number of patients who were vaccinated with the AstraZeneca COVID-19 jab have developed blood clots and one patient has died. The Danish authority emphasized that they have not opted out of the AstraZeneca vaccine, but that they are putting it on hold.
In a statement released today the Danish Health Authority said:
“Based on a precautionary principle and concerns raised by the pharmaceutical authorities, the Danish Health Authority has decided to stop vaccination with the COVID-19 vaccine from AstraZeneca for the next 14 days. The Danish Health Authority and the Danish Medicines Agency will re-evaluate this decision in week 12.”
The EU medicines agency has highlighted that there is no indication the vaccine had caused blood clots but it will be is now launching an investigation.
The Danish Health Authority also stated that:
“Against this background, the European Medicines Agency has launched an investigation into the AstraZeneca vaccine. One report relates to a death in Denmark. At present, it cannot be concluded whether there is a link between the vaccine and the blood clots.”
On Twitter Danish health minister Magnus Heunicke said:
“It is currently not possible to conclude whether there is a link. We are acting early, it needs to be thoroughly investigated”
To date, there is no concrete evidence to suggest the blood clots are linked to the vaccine and such incidents have not been reported in the United Kingdom. Close to 23 million people in the UK have received at least one dose of a COVID-19 vaccine, of which approximately 11 million have had the AstraZeneca/Oxford vaccine.